Qualigen Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of September 2023: 4.81x

Qualigen Therapeutics Inc cash flow reinvestment rate. Qualigen Therapeutics Inc (QLGN) has a Cash Flow Reinvestment Rate of 4.81x as of September 2023, reinvesting $4.47 Million (capex $246.42K plus investments $4.23 Million) from operating cash flow of $929.74K. Explore QLGN operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

4.81x

(Capex + Investments) / Operating CF

Total Reinvested

$4.47 Million

Capex + Investments

Operating Cash Flow

$929.74K

USD

Capital Expenditures

$246.42K

USD

Cash Flow Reinvestment Rate of Qualigen Therapeutics Inc (2019–2019)

Cash flow reinvestment rate of Qualigen Therapeutics Inc from 2019 to 2019. Historical reinvestment intensity for Qualigen Therapeutics Inc across 1 annual periods. Explore QLGN capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Qualigen Therapeutics Inc Cash Flow Reinvestment Rate by Year (2019–2019)

Qualigen Therapeutics Inc cash flow reinvestment rate by year from 2019 to 2019. Year-by-year capital reinvestment analysis for Qualigen Therapeutics Inc. For the full cash flow conversion analysis, see QLGN cash flow metrics.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2019	6.78x	$388.95K	$57.33K	$194.48K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow